Polysialic acid is an anti-adhesive protein modification that promotes cell migration and the plasticity of cell interactions. Because so few proteins carry polysialic acid, we hypothesize that polysialylation is a protein specific event and that a specific polysialyltransferase-substrate interaction is the basis of this specificity. The major substrate for the polysialyltransferases is the neural cell adhesion molecule, NCAM. Previous work demonstrated that the first fibronectin type III repeat of NCAM (FN1) was necessary for the polysialylation of the N-glycans on the adjacent immunoglobulin domain (Ig5) (Close et al. (2003) J. Biol. Chem. 278, 30796-30805). This suggested that FN1 may be a recognition site for the polysialyltransferases. In this study, we show that the second fibronectin type III repeat (FN2) of NCAM cannot replace FN1. Arg substitution of three unique acidic amino acids on the surface of FN1 eliminated polysialylation not only of a minimal Ig5-FN1 substrate, but also of full length NCAM. Ala substitution of these residues eliminated Ig5-FN1 polysialylation but not that of full length NCAM, suggesting that the two proteins are interacting differently with the enzymes and that multiple residues are involved in the enzyme-NCAM interaction. Using another truncated protein, Ig5-FN1-FN2, we confirmed the importance of enzyme-substrate positioning for optimal recognition and polysialylation. In sum, we have found that acidic residues on the surface of FN1 are part of a larger protein interaction region that is critical for NCAM recognition and polysialylation by the polysialyltransferases.
Polysialic acid is an anti-adhesive protein modification that promotes cell migration and the plasticity of cell interactions. Because so few proteins carry polysialic acid, we hypothesize that polysialylation is a protein specific event and that a specific polysialyltransferase-substrate interaction is the basis of this specificity. The major substrate for the polysialyltransferases is the neural cell adhesion molecule, NCAM. Previous work demonstrated that the first fibronectin type III repeat of NCAM (FN1) was necessary for the polysialylation of the N-glycans on the adjacent immunoglobulin domain (Ig5) (Close et al. (2003) J. Biol. Chem. 278, [30796] [30797] [30798] [30799] [30800] [30801] [30802] [30803] [30804] [30805] . This suggested that FN1 may be a recognition site for the polysialyltransferases. In this study, we show that the second fibronectin type III repeat (FN2) of NCAM cannot replace FN1. Arg substitution of three unique acidic amino acids on the surface of FN1 eliminated polysialylation not only of a minimal Ig5-FN1 substrate, but also of full length NCAM. Ala substitution of these residues eliminated Ig5-FN1 polysialylation but not that of full length NCAM, suggesting that the two proteins are interacting differently with the enzymes and that multiple residues are involved in the enzyme-NCAM interaction. Using another truncated protein, Ig5-FN1-FN2, we confirmed the importance of enzyme-substrate positioning for optimal recognition and polysialylation. In sum, we have found that acidic residues on the surface of FN1 are part of a larger protein interaction region that is critical for NCAM recognition and polysialylation by the polysialyltransferases.
Many proteins are modified by glycans as they move through eukaryotic secretory pathway. The glycans found on proteins can impact their folding, stability and function, and mediate or modulate cell interactions when expressed on the cell surface (1) . Polysialic acid is a developmentally regulated, anti-adhesive glycan that terminates N-or O-linked oligosaccharides found on a select group of glycoproteins (for reviews see (2) (3) (4) ). In mammals, it is generally found as a linear homopolymer of α2, 8-linked 5-N-acetylneuraminic acid that can extend to lengths of 50-100 units (5, 6) . Polysialylation is unusual among carbohydrate modifications in that it is found on only a small number of mammalian proteins. These include the α subunit of the voltage dependent sodium channel (7) (8) (9) , a form of the CD36 scavenger receptor found in milk (10) , the two polysialyltransferases, ST8Sia IV/PST (PST) abundant carrier of polysialic acid in mammals (13) (14) (15) .
NCAM is an adhesion molecule that mediates cell adhesion through homophilic trans interactions and also participates in many heterophilic interactions that frequently lead to the activation of signal transduction cascades (reviewed in (16, 17) ). NCAM belongs to the immunoglobulin superfamily and has an ectodomain consisting of five immunoglobulin-like (Ig) domains, Ig1-Ig5, and two fibronectin type III (Fn-III) repeats, FN1 and FN2 (13) (Fig.1 ). There are six reported sites for Nlinked glycosylation in the NCAM protein, of which sites five and six present on the Ig5 domain carry the majority of polysialic acid (18) (Fig.1) . The polysialyltransferases PST and STX function to polysialylate NCAM's glycans and their expression, like that of polysialic acid, is developmentally regulated (reviewed in (19) ).
The presence of polysialic acid on NCAM's glycans has been shown to negatively modulate cell interactions. Several studies in which polysialic acid was removed from NCAM using a specific endoneuraminidase showed that its presence on the glycans of NCAM's Ig5 domain not only attenuates NCAM-NCAM interactions, but also decreases or eliminates NCAMindependent cell interactions leading to impaired axon guidance and pathfinding, neurite outgrowth, and cell migration (20) (21) (22) (23) (24) . More recent biophysical studies by Johnson et al. (25) directly demonstrate that that polysialic acid on NCAM both enhances intermembrane repulsion and abolishes NCAM-mediated and cadherin-mediated membrane interactions.
While polysialic acid is highly expressed in embryos and neonates, it is largely down-regulated in the adult animal (15, 26, 27) . Interestingly, its expression persists in specialized areas of the adult brain, including the hippocampus, olfactory bulb (olfactory neuron precursors), and suprachiasmatic nucleus (location of the circadian clock), where continued cell migration, neurogenesis and synaptic plasticity are necessary (28) (29) (30) . Using mice null for NCAM or the polysialyltransferases, investigators have evaluated the functional role of NCAM and polysialic acid. Mice lacking NCAM exhibit no obvious developmental defects, but do show a reduction in the size of olfactory bulb as well as deficits in spatial learning that are likely due to the absence of polysialylated NCAM in the hippocampus (31) . In line with these observations and suggesting the importance of polysialic acid, evaluation of PST and STX null mice show that the expression of these enzymes, and thus polysialic acid, are critical for long-term potentiation, long-term depression, axon guidance and synapse formation in the hippocampus (32, 33) . STX null mice also exhibit a higher exploratory drive and a reduced fear response relative to wild type animals (32) . Taken together, these results suggest that polysialylated NCAM, and polysialic acid in particular, plays an important role in maintaining plasticity in certain areas of adult central nervous system, which in turn is important for various behaviors, as well as learning and memory. In addition, polysialic acid is also re-expressed on the surface of metastatic cancer cells such as small cell lung carcinoma (34, 35) , Wilms' tumor (36) and some neuroblastomas (6, 37) , where it is believed to promote tumor cell growth and metastasis (38, 39) .
The very small number of mammalian proteins modified by polysialic acid, coupled with the observation that the efficiency of PST-and STX-catalyzed polysialylation of NCAM attached glycans is dramatically higher than that of free oligosaccharides ( 4 0 ) , s u g g e s t s polysialylation is likely to be a protein specific modification event that requires the polysialyltransferases to recognize their substrates via an initial protein-protein interaction. Early work by Nelson et al. (18) suggested that the minimal NCAM protein capable of polysialylation by the polysialyltransferases present in the F11 dorsal root ganglion/mouse neuroblastoma cell line was a membrane-associated protein consisting of Ig4, Ig5 and FN1. Later work from our laboratory demonstrated that a smaller protein consisting of Ig5 and FN1, in either a membrane-associated or soluble form, was able to be polysialylated by either PST or STX (41) . In contrast, transmembrane or soluble proteins containing just Ig5 were folded and trafficked properly but not polysialylated. These results demonstrated that the glycans on Ig5 required the presence of the adjacent FN1 domain for polysialylation, and led to the proposal that FN1 may be the recognition and docking site for the polysialyltransferases. (41) .
In the present work, we began by addressing two questions. First, can other Fn-III repeats replace FN1? Second, are specific sequences of FN1 required for polysialylation? Demonstration of a requirement for FN1 and specific amino acids of FN1 for polysialylation would confirm the protein specificity of the process and strongly suggest that the polysialyltransferases specifically recognize this domain adjacent to their site of action (the N-glycans on Ig5). In the present study, we found that FN2 cannot functionally replace FN1 to allow polysialylation, and that Asp 511, Glu 512 and Glu 514 form a unique acidic patch on the surface of FN1 that plays an important role in the recognition and polysialylation of NCAM by the polysialyltransferases. Other studies demonstrate that the acidic patch is likely to be part of a larger protein interaction region and that the positioning of substrate relative to the membrane-associated polysialyltransferases is critical for optimal enzymesubstrate interactions and polysialylation.
MATERIALS AND METHODS
Tissue culture media and reagents, including Dulbecco's modified Eagle's medium (DMEM), Opti-MEM I, Lipofectin and fetal bovine serum (FBS) were purchased from Invitrogen Corporation (Carlsbad, CA Construction of epitope-tagged, NCAM FN1 deletion mutant protein, ΔFN -The ΔFN1 construct was generated from human NCAM 140 by two PCR amplifications using the Vent DNA polymerase. To generate amino terminus of Δ FN1, oligonucleotide primers 5'-GATA TCCTGCAGGTGGATATTGTTCCCAGC-3' and 5'-TCTAGAGCTGCTTGAACA-AGGATGAATTCC-3' were used to amplify Ig1-Ig5 domains from NCAM-140 and specifically introduce an E c oRV restriction site at the 5' end and an XbaI site at the 3' end of the cDNA. Following restriction enzyme digestion, the cDNA was ligated into previously digested pcDNA3.1/V5-HisB vector DNA that already contained the signal peptide from canine pancreatic prepro-insulin (41) . The carboxy-terminus of the ΔFN1 construct was generated by PCR amplification of FN2, the transmembrane region and cytoplasmic tail of NCAM 140 using oligonucleotide primers 5'-TCTAGAACCCAGTGCACT-AAGCTCGAAGG-3' and 5'-TCTAGAC-CTGCTTTGCTCTCGTTCTCCTTTGTC-3'. The amplified fragment was subcloned into the XbaI site of the previously digested NCAM pcDNA3.1/V5-HisB vector DNA. The sequence of the new cDNA was confirmed using the Quick Denature Plasmid Sequencing Kit.
Construction of FL-NCAM and NCAM4
mutant cDNAs-The amino acids Asp 511, Glu 512 and Glu 514 were individually replaced with Arg in NCAM4 using the following mutation primers. Note that amino acid numbering is based on the mature protein starting with Leu (amino acid 20 in the pre-protein) containing the VASE exon (13, 42) . Asp 511 was mutated using, 5'-CCAGGTGCAGTTTCGTGAACCAGAGG -3' and 5'-CCTCTGGTTCACGAAAC-TGCACCTGG-3'. Glu 512 was mutated using 5'-GGTGCAGTTTGATCGACCAG-AGGCC-3' and 5'-GGCCTCTGGTCGAT-CAAACTGCACC-3'. Glu 514 was mutated t o Arg in NCAM4 using 5'-GTTTGATGAACCACGGGCCACAGGTG GG-3' and 5'-CCCACCTGTGGCCCG-TGGTTCATCAAAC-3'. The NCAM4 D511R/E512R double mutant and NCAM4 D511R/E512R/E514R triple mutant (NCAM 4-RRR) were constructed by sequentially mutating each of the two or three amino acids to Arg. The FL-NCAM-RRR mutant was created by mutating Asp 511, Glu 512 and Glu 514 simultaneously to Arg using the primers 5'-GCAGTTTCGTCGACCACGG-GCCACAGG-3' and 5'-CCTGTGGCCC-GTGGTCGACGAACTGC-3'. FL-NCAM, NCAM4 and NCAM3 triple Ala mutants were generated by simultaneously mutating Asp 511, Glu 512 and Glu 514 to Ala using the primers 5'-GCAGTTTGCTGCACC-AGCGGCCACAG-3' and 5'-CTGTGGC-CGCTGGTGCAGCAAACTGC-3'. All mutation reactions were performed using the QuikChange TM site-directed mutagenesis kit according to the manufacturer's protocol (Stratagene). All mutations were confirmed by sequencing using the Quick Denature Plasmid Sequencing Kit.
Transfection of COS-1 cells with NCAM and
PST or STX cDNAs-COS-1 cells maintained in DMEM, 10% FBS were plated on 12-mm glass coverslips or 100-mm tissue culture plates and grown in a 37°C, 5% CO 2 incubator until 50-70% confluent. Lipofectin transfections were performed according to the protocols provided by Invitrogen. Briefly, 3 µl of Lipofectin and 0.5 µg of NCAM plasmid DNA in 300 µl of Opti-MEM 1 were used for the transfection of each coverslip. For co-expression of NCAM proteins with PST or STX, 3 µl of Lipofectin and 500 µg each of NCAM and PST or STX cDNA in 300 µl of Opti-MEM 1 were used to transfect each coverslip. For transfection of tissue culture plates, 30 µl of Lipofectin and 10 µg each of NCAM and PST or STX plasmid cDNAs in 3ml of Opti-MEM 1 were used.
Immunoprecipitation and immunoblot analysis of NCAM proteins from COS-1 cells co-expressing PST and STX-COS-1 cells plated on 100-mm tissue cultures plates
were co-transfected with untagged PST or STX cDNA and V5-tagged NCAM cDNA at a 1:1 ratio. Following transfection, 7 ml of DMEM, 10% FBS was added to the cells. After incubation for 18 h at 37° C in a 5% CO 2 incubator, cells were washed with 10 ml of PBS and lysed in 1 ml of immunoprecipitation buffer (50 mM TrisHCl, pH 7.5, 150 mM NaCl, 5mM EDTA, 0.5% Nonidet P-40, 0.1% SDS). NCAM proteins were immunoprecipitated from cell lysates using 3 µl of anti-V5 epitope tag antibody and 50 µl of a 50% slurry of protein A-Sepharose, as previously described (43) . The immunoprecipitation beads were resuspended in 50 µl of Laemmli sample buffer containing 5% β -mercaptoethanol, heated for 10 min at 65°C (not heated to 100°C to preserve polysialic acid), and directly loaded into the gel wells. Immunoprecipitated proteins were separated on a 5% separating, 3% stacking SDSpolyacrylamide gel. To evaluate protein expression, a 40 µl aliquot of the cell lysate was removed before immunoprecipitation. Following the addition of Laemmli sample buffer containing 5% β-mercaptoethanol to the sample, it was incubated at 110° C for 10 min to remove polysialic acid and electrophoresed on a 7.5% separating and 5% stacking SDS-polyacrylamide gel. Following electrophoresis, proteins were electrophoretically transferred to nitrocellulose membranes for 16 h at 500mA. To detect polysialylated proteins, membranes were incubated with the OL.28 anti-polysialic acid antibody (IgM) diluted 1:40 -1:100 in blocking buffer 1 (2% nonfat dry milk in Tris-buffered saline, pH 8.0) and HRP-conjugated goat anti-mouse IgM diluted 1:8000 in blocking buffer 2 (5% nonfat dry milk in Tris-buffered saline, pH 8.0, 0.1% Tween 20) . For immunoblotting of the cell lysate aliquots, the anti-V5 epitope tag antibody was diluted 1:5000 and HRP-conjugated goat anti-mouse IgG was diluted 1:8000 in blocking buffer 2. Immunoblots were developed using the SuperSignal West Pico chemiluminescence kit (Pierce) and exposed to Kodak Bio-Max MR film at room temperature.
Immunofluorescence localization of NCAM proteins-COS-1 cells, plated on glass coverslips were transfected with the various NCAM cDNAs, and processed for immunofluorescence microscopy as described previously (41) . Briefly, cells were permeabilized with -20 °C methanol to visualize internal structures and the cell surface. Anti-V5 epitope tag antibody was diluted 1:250 and the FITC-conjugated goat anti-mouse IgG secondary antibody was diluted 1:200 in immunofluorescence blocking buffer (5% normal goat serum in PBS) prior to use. Coverslips were mounted on glass slides using 20 µl of mounting medium (15% (w/v) Vinol 205 polyvinyl alcohol, 33% (v/v) glycerol, 0.1% azide in PBS, pH 8.5). Cells were visualized and photographed using a Nikon Axiophot microscope equipped with epifluorescence illumination and a X60 oil immersion Plan Apochromat objective. Pictures were taken using an attached Spot RT Color digital camera and processed using Spot RT Software v.3.5.1 (Diagnostic Instruments Inc, Sterling Heights, MI)
Indirect immunofluoresecence microscopy of COS-1 cells co-expressing NCAM and non-autopolysialylated forms of PST and STX-COS-1 cells maintained in DMEM,
10% FBS were plated on 12-mm glass coverslips and grown in a 37° C, 5% CO 2 incubator until 50-70% confluent and transfected, as described above. Each coverslip was transfected with polysialyltransferase and NCAM cDNA at a 1:1 (0.5:0.5 µg) ratio. Here catalytically active, mutant forms of the polysialyltransferases, PST Mut 2.3 and STX Mut 2.4.5, which lack the oligosaccharides that are autopolysialylated, were used so that only polysialylated NCAM proteins would be visualized. Cells were fixed and processed for immunofluorescence microscopy and visualized, as described above. Primary antibody, OL.28 anti-polysialic acid antibody, and secondary FITC-conjugated goat anti-mouse IgM antibody were diluted 1:200 in blocking buffer for these experiments.
Structural Modeling of FN1-The structure of FN1 of human NCAM was modeled based on NMR solution structure of FN2 of rat NCAM. This was done using SwissModel First Approach Mode which is a fully automated protein structure homology-modeling server accessible via the ExPASy web server. First the amino acid sequences of FN1 and FN2 were aligned using T-COFFEE, a multiple sequence alignment tool (44) . The aligned sequence and structure of FN2 was then used by SWISS-MODEL to predict the structure of FN1. The two structures were then subjected to surface charge distribution analysis by GRASP (Graphical Representation and Analysis of Structural Properties).
RESULTS

FN2 cannot replace FN1 in mediating NCAM recognition and polysialylation by PST and STX.
Our previous work demonstrated that NCAM4, consisting of Ig5, which contains the polysialylated Nglycans, and the adjacent Fn-III repeat (FN1), is the minimal NCAM protein that can be polysialylated by PST and STX (41) . This suggested that FN1 was necessary for polysialylation and may constitute an enzyme recognition site. We predict that the polysialyltransferases first recognize and dock with FN1 of NCAM and that this is necessary not only for the specificity of polysialylation, but could also impact the extent of polymerization of polysialic acid on the N-glycans of the adjacent Ig5 domain. In the present study we wanted to further evaluate the role of the FN1 in mediating recognition and polysialylation by the polysialyltransferases. To do this, we determined whether FN1 could be replaced by FN2 of NCAM, and performed a mutagenesis analysis of FN1 based on information gained from modeling the structure of FN1 on the known structure of rat FN2.
To determine whether other Fn-III repeats are capable of replacing FN1 of NCAM, we generated a FN1 deletion mutant using human NCAM-140 as a template. In this deletion mutant, ΔFN1, we essentially replaced FN1 with FN2 ( Fig. 1,  ΔFN1 ). ΔFN1 was made as a membraneassociated form containing the transmembrane region and cytoplasmic tail and was cloned into the pcDNA3.1/V5-His B vector, which places a V5 epitope tag and a His 6 epitope tag at the carboxy-terminus of the protein. First, we evaluated the localization of ΔFN1 to ensure that the protein folded correctly and was transported to the cell surface. FL-NCAM and ΔFN1 were transiently expressed in COS-1 cells and their localization analyzed by immunofluorescence microscopy in permeabilized cells using an anti-V5 epitope tag antibody and a FITC-conjugated goat anti-mouse IgG secondary antibody, as described in Methods. We found that both FL-NCAM and ΔFN1 were localized at the cell surface ( Fig. 2A, Localization) . Golgi staining was also apparent in the cells expressing these proteins and reflects their trafficking through this compartment. These results indicated that ΔFN1 was folded properly and was readily transported from the endoplasmic reticulum, through the Golgi, and to the plasma membrane.
N e x t w e e v a l u a t e d t h e polysialylation of Δ FN1 by the polysialyltransferases using two separate assays. The first assay is an immunofluorescence assay employing the OL.28 anti-polysialic acid antibody and nonautopolysialylated mutant forms of the two polysialyltransferases, PST Mut 2.3 and STX Mut 2.4.5. These proteins lack the oligosaccharides that are modified with polysialic acid, but remain catalytically active (43) . We have previously shown that the mutant enzymes can polysialylate coexpressed NCAM, but they do not polysialylate any endogenous glycoproteins in COS-1 cells (43) . We transiently expressed FL-NCAM and ΔFN1 with the catalytically active, non-autopolysialylated PST Mut 2.3 and STX Mut 2.4.5 in COS-1 cells. The cells were immunostained with the OL.28 anti-polysialic acid antibody to evaluate polysialylation of the NCAM proteins. We found that unlike FL-NCAM, Δ FN1 was not polysialylated by coexpressed PST Mut 2.3 and STX Mut 2.4.5 ( Fig. 2A, Polysialylation) . A small amount of polysialic acid was observed in the Golgi of some cells and is likely due to an overexpression of both NCAM and polysialyltransferases and their concentration in this compartment. These results suggest that FN2 cannot functionally replace FN1.
Our second assay confirmed these results. In this assay we co-expressed V5-tagged FL-NCAM and ΔFN1 with untagged, wild type PST and STX in COS-1 cells. NCAM proteins were immunoprecipitated from cell lysates using the anti-V5 epitope tag antibody, and subjected to SDS-PAGE and immunoblotting with the OL.28 antipolysialic acid antibody. Again, in contrast to FL-NCAM, ΔFN1 was not polysialylated by the co-expressed polysialyltransferases (Fig. 2B, OL.28 antibody, Polysialylation). To assess relative levels of protein expression, aliquots of NCAM proteins were heated at high temperature to remove polysialic acid and immunoblotted with anti-V5 epitope-tag antibody (Fig. 2B , Anti-V5 antibody, Expression). Both ΔFN1 and FL-NCAM were expressed at relatively equal levels, suggesting that the lack of detectable polysialylation of ΔFN1 is not due to low expression levels. These results show that FN2 cannot functionally replace FN1 in the polysialylation process and that FN1 is necessary for the recognition and polysialylation of NCAM.
Structural modeling predicts an acidic patch on the surface of FN1 repeat that is absent in FN2.
To investigate the specific features of FN1 that are necessary for NCAM recognition and polysialylation by polysialyltransferases, we carried out a systematic analysis of the sequence and structure of FN1. The Fn-III repeat is a defined structural domain that is found in approximately 2% of all animal proteins and is characterized by a similar fold rather than by strict amino acid sequence homology (45). Since FN2 was not able to replace FN1 in mediating polysialyltransferase recognition and polysialylation, we compared the structures and sequences of these two domains. We modeled the structure of FN1 based on the previously solved NMR structure of the rat NCAM FN2 domain (46) by the first approach mode of the SWISS-MODEL software. Initially, the sequences of FN1 and FN2 of human NCAM were compared and aligned using T-COFFEE Version 1.41 alignment software which generated the optimal sequence alignment by inserting gaps into both sequences. The aligned sequences were then used to generate PDB structure files by SWISS-MODEL. A charge distribution analysis of the structures of FN1 and FN2 repeats using GRASP (Graphical Representation and Analysis of Structural Properties) software was then performed. We noticed a negatively charged patch (Fig.  3A) consisting of Asp 511, Glu 512 and Glu 514 in NCAM's FN1 repeat (these correspond to Asp 23, Glu 24 and Glu 26 in the isolated FN1 repeat) (Fig. 3B) . Interestingly, this prominent, negatively charged patch is absent from the surface of FN2. In fact, an optimal alignment of FN1 and FN2 sequences by the T-COFFEE Version 1.41 alignment software suggests that these three acidic residues in FN1 are replaced by Asn, Leu, and Gln in FN2.
Acidic amino acids on the surface of FN1 i n N C A M 4 c o n t r i b u t e t o polysialyltransferase recognition and polysialylation.
We next considered the possibility that Asp 511, Glu 512 and Gln 514 on the surface of FN1 form part of binding site mediating the interaction of NCAM with the polysialyltransferases. Alternatively, this predicted acidic patch could mediate the interaction of FN1 with Ig5 leading to the stabilization of an Ig5 conformation optimal for polysialylation. In either case, replacing these relatively small, negatively charged residues with large, positively charged Arg residues should interfere with these possible protein-protein interactions if they exist.
We first simultaneously changed Asp 511, Glu 512 and Glu 514 to Arg in the NCAM4 protein (Ig5-FN1) to generate NCAM4-RRR, and evaluated its localization and polysialylation.
Indirect immunofluorescence microscopy using the anti-V5 tag antibody demonstrated that, like NCAM4, NCAM4-RRR is transported through the Golgi to the cell surface (Fig.  4A, Localization) . A misfolded protein would be recognized by chaperones and retained in the endoplasmic reticulum and/or degraded (47) . The ability of NCAM4-RRR to be transported efficiently to the cell surface argues strongly that the amino acid substitutions did not grossly misfold the protein.
N e x t , w e e v a l u a t e d t h e polysialylation of NCAM4-RRR protein by catalytically active, non-autopolysialylated PST Mut 2.3 using our immunofluorescence assay, as described above. We found that, while NCAM4 was highly polysialylated, NCAM4-RRR did not carry any detectable polysialic acid when co-expressed with PST Mut 2.3 (Fig. 4A, Polysialylation) . To c o n f i r m t h e r e s u l t s o f t h e immunofluorescence experiment, we coexpressed NCAM4 and NCAM4-RRR with PST, recovered the NCAM proteins by immunoprecipitation, and subjected the immunoprecipitated proteins to immunoblot analysis with OL.28. This analysis clearly shows that NCAM4-RRR is not detectably polysialylated by PST (Fig. 4B, OL.28 antibody, Polysialylation) even though it is expressed at nearly identical levels as unaltered NCAM4 (Fig. 4B , Anti-V5 antibody, Expression). Thus, replacing the Asp 511, Glu 512, and Glu 514 with positively charged Arg residues eliminates recognition and polysialylation of NCAM4 by PST. Other replacements of FN1 charged, surface amino acids, including Asp 577, Asp 583, Lys 523, Lys 525 and Lys 558, had little to no impact on polysialylation 2 , indicating that the effect we observe following the replacement of Asp 511, Glu 512 and Glu 514 is specific. These data highlight the protein specificity of the polysialylation process and suggest that the unique acidic patch found on the surface of the FN1 repeat of NCAM plays an important role in NCAM recognition and polysialylation by the polysialyltransferases.
The simultaneous replacement of Asp 511, Glu 512 and Glu 514 is required to completely eliminate PST recognition and polysialylation of NCAM 4.
To further investigate the contribution of each individual amino acid towards the recognition and polysialylation of NCAM4 by PST, we individually replaced Asp 511, Glu 512 and Glu 514 with Arg residues (D511R, E512R and E514R). We first analyzed their expression and localization in the cell by immunofluorescence microscopy and found that all three single mutants were efficiently transported out of the ER, through the Golgi, and to the cell surface (data not shown). Next we compared the polysialylation of NCAM4, D511R, E512R and E514R and NCAM4-RRR by coexpressing these proteins with PST, and subjecting the immunoprecipitated proteins to immunoblotting with OL.28. We found that while the polysialylation of NCAM4-RRR was completely eliminated, all of the three single amino acid replacement proteins still carried polysialic acid (Fig. 5A, OL.28 antibody, Polysialylation). This was not the result of differential expression because an anti-V5 epitope tag immunoblot of cell lysate aliquots demonstrated that all proteins were expressed at relatively equal levels (Fig. 5A , Anti-V5 antibody, Expression). Interestingly, the E514R mutant migrates with a decreased molecular weight compared to the other polysialylated NCAM proteins, suggesting that less polysialic acid may be added to this mutant. In sum, all three acidic amino acids need to be replaced by Arg to eliminate polysialylation by PST.
Replacement of acidic amino acids in FN1 decreases polysialyltransferase recognition and polysialylation of full length NCAM.
Previous work by Nelson et al. (18) suggested that Ig4 might also play a role in NCAM polysialylation. While a transmembrane NCAM protein consisting of Ig4 and Ig5 was not polysialylated 3 , and no other domain in the NCAM protein was able to restore polysialylation of ΔFN1 protein (Fig. 2) , we still considered the possibility that, in the presence of FN1, other regions of FL-NCAM might be able to compensate for the absence of the three acidic residues in FN1. To investigate this possibility, we generated the same Arg replacements in the FL-NCAM protein (FL-NCAM-RRR). FL-NCAM-RRR was transiently expressed in COS-1 cells and localized by immunofluorescence microscopy. We found that both FL-NCAM and FL-NCAM-RRR are efficiently transported through Golgi and expressed on cell surface (Fig. 6A,  Localization) . To analyze the polysialylation of FL-NCAM-RRR protein, we coexpressed it with PST and subjected the immunoprecipitated proteins to OL.28 immunoblot analysis. We observed that the polysialylation of FL-NCAM-RRR was dramatically reduced in comparison to FL-NCAM (Fig. 6B, OL.28 antibody, Polysialylation). Once again we immunoblotted aliquots of the NCAM proteins with anti-V5 epitope tag antibody to assess protein expression and found that both proteins were expressed at relatively similar levels (Fig. 6B , Anti-V5 antibody, Expression). These results showed that replacing Asp 511, Glu 512 and Glu 514 with Arg dramatically reduced both FL-NCAM and NCAM4 polysialylation without significantly altering their transport through the secretory pathway. No other domains of the FL-NCAM could compensate for the replacement of these amino acids, demonstrating that the FN1 repeat is necessary for NCAM polysialylation and suggesting that these acidic residues play a role in the recognition and polysialylation of NCAM by the polysialyltransferases.
Replacing the FN1 acidic residues Asp 511, Glu 512 and Glu 514 with Ala also reduces polysialylation of NCAM4 but has less impact on the polysialylation of FL-NCAM. Individual replacement of the three acidic amino acids demonstrated that all three needed to be changed to Arg to eliminate polysialylation (Fig. 5) . We reasoned that if Asp 511, Glu 512 and Glu 514 constitute the entire protein interaction site, then even replacing these residues with a small, neutral amino acid like Ala should eliminate polysialylation. In contrast, if these three acidic residues are only part of a larger protein interaction region, large positively charged Arg residues might be sufficient to eliminate the protein interactions and polysialylation, while small, neutral Ala residues would not be able to disrupt other interactions in the larger site. To distinguish between these two possibilities, we replaced the Asp 511, Glu 512 and Glu 514 with Ala in both the NCAM4 and FL-NCAM proteins to generate NCAM4-AAA and FL-NCAM-AAA. We first confirmed their delivery to the cell surface using immunofluorescence microscopy (data not shown). We then coexpressed NCAM4-AAA and FL-NCAM-AAA with PST to analyze their polysialylation. Interestingly, while the polysialylation of NCAM4-AAA was substantially decreased relative to the unaltered NCAM4, the polysialylation of FL-NCAM-AAA was only marginally decreased relative to unaltered FL-NCAM (Fig. 7, OL.28 antibody, Polysialylation).
One difference between FL-NCAM and NCAM4 is the distance of the Ig5-FN1 unit from the membrane. In FL-NCAM, the Ig5-FN1 unit is separated from the transmembrane region by FN2 and intervening sequences, while in NCAM4 the entire FN2 domain and the sequences between FN2 and the transmembrane region are missing. We considered the possibility that distance of the Ig5-FN1 unit from the membrane in FL-NCAM is optimal for interaction with the membrane-associated polysialyltransferases and that the greater effect we observe on the polysialylation of the NCAM4-AAA mutant is the result of a strained or partial interaction between NCAM4 and PST. We hypothesize that PST may be interacting with NCAM4 over a smaller area of the FN1 domain than it does with the FN1 of FL-NCAM, and that this might explain why both Arg and Ala replacements have a substantial effect on NCAM4 polysialylation, while only the more drastic Arg replacement has an effect on FL-NCAM polysialylation.
To test this idea, we used another mutant NCAM protein, NCAM3, which is a transmembrane protein consisting of Ig5, FN1 and FN2 (Fig.1) . NCAM3 is similar to FL-NCAM in terms of the distance between the Ig5-FN1 unit and the membrane. If the positioning of the Ig5-FN1 relative to the membrane is a factor in NCAMpolysialyltransferase interactions, then we would expect that the polysialylation of a NCAM3-AAA protein would be more similar to that of the FL-NCAM-AAA. As predicted, we observed little reduction in the intensity of OL.28 staining of NCAM3-AAA (Fig. 7) . However, we did see a shift in the molecular mass of polysialylated NCAM3 suggesting that, while polysialylation is not eliminated on NCAM3, the amount of sialic acid added may be somewhat decreased. Taken together, the results suggest that Asp 511, Glu 512 and Glu 514 are part of a larger site on the surface of the FN1 repeat of NCAM that is necessary for NCAM recognition and polysialylation by the polysialyltransferases. The results also suggest that the distance of the Ig5-FN1 unit from the membrane and its positioning relative to the catalytic domains of the polysialyltransferases plays a role in the efficiency of recognition by the enzymes and subsequent polysialylation.
DISCUSSION
Our previous evaluation of domain requirements for NCAM polysialylation demonstrated that FN1 was necessary for the recognition and polysialylation of N-glycans on the adjacent Ig5 domain (41) . In present study we wanted to rule out the possibility that any Fn-III repeat placed carboxyterminal to the Ig5 domain would be sufficient for polysialylation of the glycans on Ig5, and provide additional support for our hypothesis that a protein-protein interaction requiring specific FN1 amino acids is necessary for polysialylation.
With these two issues in mind, we evaluated whether FN1 could be replaced by other Fn-III repeats and found that FN2 of NCAM cannot replace FN1 (Fig. 2) . Modeling the FN1 domain on the known structure of FN2 revealed a unique acidic patch comprised of Asp 511, Glu 512 and Glu 514 on the surface of FN1 that was missing from the equivalent surface of FN2 (Fig. 3) . Replacing these three acidic residues with Arg in either NCAM4 (Ig5-FN1) or FL-NCAM eliminated or substantially decreased polysialylation of these proteins (Fig. 4 and 6) . Interestingly, replacing the three acidic residues with Ala eliminated polysialylation of NCAM4 but not FL-NCAM. Based on our experiments with NCAM3 shown in Figure 7 , we attribute this difference in the impact of the Ala mutations to differences in the placement of the Ig5-FN1 unit of these two proteins relative to the membrane-associated polysialyltransferase catalytic domain. We predict that the interaction of PST with NCAM4 involves fewer residues on the surface of FN1 than does the interaction of PST with FL-NCAM. These results, and those in Figure 5 , which demonstrate that all three acidic amino acids must be replaced to eliminate polysialylation of the NCAM proteins, suggest that multiple contacts with surface residues of FN1 are involved in NCAM recognition by the enzymes.
The protein specificity of polysialylation is supported by the existence of a limited number of polysialyltransferase substrates in mammalian cells, as well as the data presented in this work demonstrating a requirement for NCAM's FN1 repeat and specific amino acids in this repeat for the polysialylation of N-glycans on the adjacent Ig5 domain. As with other carbohydrate addition or modification events that have been shown to be protein specific (reviewed in (48)), we believe that NCAM polysialylation requires an initial proteinprotein interaction between NCAM and a polysialyltransferase. In these other proteinspecific modification events, the interaction between enzyme and substrate involves multiple amino acid contacts and large recognition regions or signal patches on the substrate. For example, the recognition of the lysosomal enzyme cathepsin D by Nacetylglucosamine-1-phosphotransferase, the first enzyme in a two-step synthesis of the mannose 6-phosphate targeting signal on lysosomal enzymes, requires maintenance of cathepsin D tertiary structure and a signal patch consisting of a specific Lys residue and the β-loop of the carboxyl lobe of this lysosomal enzyme (49, 50) . A weaker Nacetylglucosamine-1-phosphotransferase recognition domain is also found on the amino lobe of this aspartyl protease (51, 52) . Another example of a protein specific modification is the biosynthesis of the GalNAc-4-SO 4 structure on the termini of the N-glycans of pituitary glycoprotein hormones (48) . This glycan structure is recognized by a receptor that mediates hormone clearance from the circulation (53) . The N-acetylgalactosaminyltransferase that catalyzes the first step in the biosynthesis of the terminal GalNAc-4-SO 4 structure on the hormone N-glycans, recognizes an α helical stretch of basic amino acids 6-9 amino acids amino-terminal to the N-glycan to be modified (54, 55) . In this case, maintenance of substrate tertiary structure is not required.
When considering the potential roles the FN1 domain could play in NCAM polysialylation, the simplest possibility is that this domain acts as a recognition and docking site for the polysialyltransferases, which after they bind, can then polysialylate the N-glycans on the adjacent Ig5 domain. In addition, enzyme binding to the FN1 domain may not be solely the basis for the protein specificity of polysialylation, but could also be critical for the polymerization of the polysialic acid chains. Affinity of binding between polysialyltransferase and NCAM may even control the length of the polysialic acid chains. Another possibility is that the Ig5 and FN1 domains interact in a specific configuration to form a binding site, and that the region of the FN1 domain containing the acidic residues is critical for this interaction. While the presence of a flexible hinge between the Ig5 and FN1 domains (56) (57) (58) makes this an attractive possibility, based on the data presented in this work and the rationale described below, we favor the former possibility that FN1 acts a s a d o c k i n g s i t e f o r t h e polysialyltransferases.
If Ig5 and FN1 together form a binding site and an interaction between Ig5 and FN1 is necessary for recognition by the enzymes and is disrupted in a particular mutant, then this should impact the polysialylation of both NCAM4 and FL-NCAM in an identical negative way. However, while we observe similar effects of the FN1 triple Arg mutants on NCAM4 and FL-NCAM polysialylation, we see different effects of the FN1 triple Ala mutants on NCAM4 and FL-NCAM polysialylation. On the other hand, if enzyme-NCAM interaction requires that the polysialyltransferase contact a site on the surface of FN1 that is made up of several distinct residues, then positioning of the NCAM protein relative to the membraneassociated enzyme may alter the extent of that contact and thus how different mutations impact contact. In this regard, we believe that it is more likely that the interaction between FL-NCAM and PST is optimal and involves several amino acid contacts so that only the more drastic Arg replacements can disrupt the other interactions between enzyme and substrate. In contrast, the interaction between NCAM4 and PST may involve fewer amino acid contacts so that even replacement with Ala residues is detrimental and abrogates enzyme-substrate interaction. This premise is supported by the observation that the triple Ala mutations impact the polysialylation of NCAM3 and FL-NCAM similarly, and the positioning of the Ig5-FN1 unit relative to the membrane and PST is identical for both these proteins.
Fibronectin type I, II and III repeats were first identified in fibronectin (59) , and were subsequently found in many other proteins (45) . The Fn-III repeat is the largest of the three consisting of approximately 90 amino acids (45) . Fn-III repeats are also the most common of the three Fn domains and are found in a variety of neural cell adhesion molecules, receptor protein kinases and phosphatases, adhesive matrix proteins, cytokine receptors, cytoplasmic muscle proteins and prokaryotic carbohydrate cleavage enzymes (reviewed in (45) (17)). This interaction activates the FGF receptor and is believed to be critical for NCAM-mediated neurite outgrowth (60, 61) . NCAM also binds and hydrolyzes ATP (62) (63) (64) and the ATP binding site has been located on FN2 (46) . NCAM has also been shown to interact with the prion protein and both its FN1 and FN2 repeats are involved in this interaction (65) .
Numerous structural studies have demonstrated that while the Fn-III repeats of neural adhesion molecules do not exhibit significant sequence homology, they do share similar topology resembling that of an immunoglobulin constant domain (66) (67) (68) . Each Fn-III repeat contains seven β strands that are arranged in two antiparallel β sheets consisting of three or four strands each (66) (67) (68) . The three acidic residues of FN1 that we have found to be critical for NCAM polysialylation are predicted to be located in a linker region between strands B and C (see (18) ). Analysis of FN1 sequences from NCAM proteins from species ranging from man to Xenopus show that these three residues are conserved in all species except for Xenopus in which Glu 514 is conservatively replaced with Asp (69). Interestingly, a related protein, fasciclin II (NCAM2) shares NCAM's domain structure and possesses N-glycans at identical positions in the Ig5 domain, but has nonconservative alterations in two of the three FN1 amino acids we have found to be important for NCAM polysialylation (70) . Whether this protein is polysialylated by PST and STX is not known and will be important to determine. Future studies will focus on directly demonstrating a proteinprotein interaction between NCAM and the polysialyltransferases and defining the structure of NCAM's FN1 domain and the protein interaction site in more detail in both NCAM and other substrates. Prior to staining, cells were fixed with methanol to visualize both surface and internal structures. B, FL-NCAM and ΔFN1 were co-expressed in COS-1 cells with PST and STX, immunoprecipitated from cell lysates, and subjected to immunoblot analysis using the OL.28 anti-polysialic acid antibody (OL.28 antibody, Polysialylation). Molecular mass marker: 194 kDa, myosin. To assess relative levels of NCAM protein expression, aliquots of cell lysates were heated to 110°C to remove polysialic acid and immunoblotted with anti-V5 epitopetag antibody (Anti-V5 antibody, Expression). Fig. 3 . Structural modeling predicts an acidic patch present on the surface of FN1 that is absent in FN2. A, The structure of FN1 was modeled on the NMR solution structure of rat FN2 by the first approach mode of SWISS-MODEL software which aligned the sequence of FN1 and FN2 with the T-COFFEE, Version 1.41 alignment software. Following this the charge distribution analysis of the two structures was performed using GRASP (Graphical Representation and Analysis of Structural Properties) software. Structure modeling predicted a unique negatively charged patch present on the surface of FN1 repeat that was not present on the surface of FN2. This surface patch consists of amino acids Asp 511, Glu 512 and Glu 514 (numbering begins at the first amino acid of the mature protein Leu 20 and includes the 10 amino acid VASE exon found in Ig4 (13, 42) ). In FN2 these residues are replaced by Asn, Leu and Gln, respectively. Residue numbers are presented both as found in the entire NCAM protein (D511, E512, E514) and as found in an isolated FN1 domain (D23, E24, E26) . B, The amino acid sequence of the FN1 repeat is shown with the amino acids forming the acidic patch indicated in red. Other amino acids that were changed with no impact on polysialylation are indicated in bold. Fig. 4 . Replacing Asp 511, Glu 512 and Glu 514 with Arg eliminates polysialylation of NCAM4 by PST. A, COS-1 cells transiently expressing NCAM4 and NCAM4 D511R/ E512R/ E514R (NCAM 4-RRR) were analyzed by indirect immunofluorescence microscopy using the anti-V5 epitope tag primary antibody to assess protein localization (Localization). COS-1 cells co-expressing NCAM4 and NCAM4-RRR with non-autopolysialylated, catalytically active PST Mut 2.3 were stained with OL.28 anti polysialic acid antibody to assess polysialylation (Polysialylation). Prior to staining, cells were fixed with methanol to visualize both surface and internal structures. B, NCAM4 and NCAM4-RRR were co-expressed in COS-1 cells with PST, immunoprecipitated from cell lysates, and subjected to immunoblot analysis using the OL.28 anti-polysialic acid antibody (OL.28 antibody, Polysialylation). Molecular mass marker: 194 kDa, myosin. To assess relative levels of NCAM protein expression, aliquots of cell lysates were heated to 110°C to remove polysialic acid and immunoblotted with anti-V5 epitope-tag antibody (Anti-V5 antibody, Expression). Fig. 5 . Asp 511, Glu 512 and Glu 514 must all be replaced to eliminate PST recognition and polysialylation of NCAM4. NCAM4 and NCAM4 mutant proteins were co-expressed in COS-1 cells with PST, immunoprecipitated from cell lysates, and subjected to immunoblot analysis using the OL.28 anti-polysialic acid antibody (OL.28 antibody, Polysialylation). Molecular mass marker: 194 kDa, myosin. To assess relative levels of NCAM protein expression, aliquots of cell lysates were heated to 110°C to remove polysialic acid and immunoblotted with anti-V5 epitopetag antibody (Anti-V5 antibody, Expression). 
